Forschungsprojekte
Ergebnisse pro Seite:
50
2018 - 2020
ISM04EU - A PROSPECTIVE, OPEN, MULTICENTRE CLINICAL TRIAL WITH ONE COHORT ANALYSING THE EFFICACY AND SAFETY OF MINIJECT IN EUROPEAN PATIENTS WITH OPEN ANGLE GLAUCOMA UNCONTROLLED BY TOPICAL HYPOTENSIVE MEDICATIONS- Prof. Dr. NorbertPfeiffer,
- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2018 - 2022
The (patho)physiological role(s) of CYP450-mediated mechanism(s) in the ophthalmic artery- Dr. CarolineManicam
2017 - 2021
Implementation of optimized childhood vision and hearing screening programms in middle-income countries in Europe- Dr. HeikeElflein,
- Prof. Dr. NorbertPfeiffer
2017
Fundus hypertonicus as risk factor for cardiovascular events - the Gutenberg Health Study- Dr. Alexander K.Schuster
2017
Visual impairment and blindness in the Gutenberg Health Study (GHS)- ChristianWolfram,
- NorbertPfeiffer
2017 - 2023
Establishment of a national register for congenital glaucoma in Germany- Univ.-Prof. Dr. Esther M.Hoffmann
2017 - 2018
Distribution and associated factors of tear fluid quantity in the general population - Results from the Gutenberg Health Study (GHS)- PD Dr. UlrikeHampel,
- Dr. AlexanderSchuster,
- Prof. Dr. NorbertPfeiffer
2017 - 2018
Anterior segment morphology and axial length in relation to self-reported birth weight in the Gutenberg Health Study (GHS)- Dr. AchimFieß,
- Univ.-Prof. Dr. NorbertPfeiffer
2017 - 2018
Vision-related Quality of Life in relation to visual acuity in both eyes in the Gutenberg Health Study (GHS)- Dr. StefanNickels,
- Univ.-Prof. Dr. NorbertPfeiffer
2017 - 2018
Association of autoantibody levels with different stages of age-related macular degeneration (AMD): Results from the Gutenberg Health Study (GHS)- Dr. ChristinaKorb,
- DominikWolters,
- Univ.-Prof. Dr. FranzGrus,
- Univ.-Prof. Dr. NorbertPfeiffer
2017
Prevalence and Assessment of Depression and Anxiety among Participants with Glaucoma in a Population-based Cohort Study: The Gutenberg Health Study- Dr. JasminRezapour,
- Univ.-Prof. Dr. ManfredBeutel
2016 - 2017
VIOLET (17613): Efficacy and safety of three different Eylea regimens in subjects with DME- PD Dr. KatrinLorenz
2016 - 2018
BI 1320.22DME: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2016 - 2019
ALBATROS - Data collection on the care situation and quality of life of patients with anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal venous occlusion- Dr. ChristinaKorb,
- PD Dr. KatrinLorenz
2016 - 2017
Visual function in relation to birth weight in the Gutenberg Health Study- Univ.-Prof. Dr. NorbertPfeiffer,
- Dr. AchimFieß
2016 - 2017
Prevalence and Assessment of Depression and Anxiety among Participants with Glaucoma in a Population-based Cohort Study: The Gutenberg Health Study- JasminRezapour,
- NorbertPfeiffer,
- ManfredBeutel
2016 - 2017
Visual function in relation to birth weight – results from the population-based Gutenberg Health Study (GHS)- AchimFieß,
- NorbertPfeiffer
2016 - 2017
Choroidal thickness and the continuum of heart failure – The Gutenberg Health Study- AlexanderSchuster,
- NorbertPfeiffer,
- PhilippWild
2016 - 2017
Distribution of iris configuration and dependency on age, refraction and lens thickness – The Gutenberg Health Study- AlexanderSchuster,
- NorbertPfeiffer
2016 - 2017
Visuospatial planning skills in amblyopic persons: Results from the Gutenberg Health Study- HeikeElflein,
- NorbertPfeiffer,
- JosefUnterrainer
2016 - 2017
Association of serum homocysteine levels and myopia – results from the Gutenberg Health Study- StefanNickels,
- NorbertPfeiffer,
- HenkBlom,
- WolfLagrèze
2016 - 2018
BI 1320.22: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema- PD Dr. KatrinLorenz
2015 - 2018
Beeinflusst die kinderärztliche Vorsorgeuntersuchung U7a die Augenbefunde bei den Schuleingangsuntersuchungen?- Dr. HeikeElflein
2015 - 2018
COLUMBUS-AMD (FYB201-C2015-01-P3): EFFICACY AND SAFETY OF THE BIOSIMILAR RANIBIZUMAB FYB201 IN COMPARISON TO LUCENTIS IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2017
Vision-related Quality of Life in the Gutenberg Health Study (GHS)- Dr. StefanNickels,
- Dr. AlexanderSchuster,
- Univ.-Prof. Dr. NorbertPfeiffer
2015 - 2018
Simbrinza GLH694-P001: Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue.- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2020
Artemis - Bimatoprost 192024_092: The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2020
PACIFIC CRFB002ADE28 - Observation of treatment regimens with lucentis during every day treatment in all approved indications- PD Dr. KatrinLorenz
2015 - 2018
Lampalizumab GX29185: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2016
IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR- Prof. Dr. NorbertPfeiffer